LBT Innovations (ASX:LBT) Share Price and News

Market Cap (28-Jan) $29,889,572 (1,428th)	Close (30-Jun) $0.030 0 (0%)	Volume (30-Jun) 960,646	Shortsold (12-Dec) 10,096 (0.00%) (692nd)
52w High $0.000	52w Low $0.000	P/E -	EPS 0

	Subject
	LBT LBT Ann: APAS Presented at ASM Conference
	1 (current) 2 3
	LBT LBT Ann: APAS Compact Extension to Project Funding Timeframe
	LBT LBT Ann: Notice under Section 708A - Cleansing Notice
	LBT LBT Ann: Application for quotation of securities - LBT
	LBT LBT Ann: Notice under Section 708A - Cleansing Notice
	LBT LBT Ann: Application for quotation of securities - LBT
	LBT LBT Ann: New Company Presentation
	LBT LBT Ann: Upcoming Investor Webinar Presentation
	LBT LBT Ann: LBT Board - Chair Transition Process
	LBT LBT Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	LBT LBT Ann: NEW APAS-AMR DATA PRESENTED AT GLOBAL CONFERENCE
	LBT LBT Ann: Notification of cessation of securities - LBT
	LBT LBT Ann: Director Retirement & Appendix 3Z
	LBT LBT Ann: Notice under Section 708A - Cleansing Notice
	LBT LBT Ann: Notification regarding unquoted securities - LBT
	LBT LBT Ann: Application for quotation of securities - LBT
	LBT LBT Ann: Proposed issue of securities - LBT
	LBT LBT Ann: Placement Supports APAS Pharma & EU Expansion
	LBT LBT Ann: Half Yearly Report and Accounts
	LBT LBT Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	LBT LBT Ann: LBT Company Presentation
	LBT LBT Ann: Quarterly Investor Call
	LBT LBT Ann: Notification of cessation of securities - LBT
	LBT LBT Ann: AstraZeneca Partners LBT for APAS Pharma Development
	LBT LBT Ann: Release from Escrow
	LBT LBT Ann: LBT Strengthens APAS Pharma Development
	LBT LBT Ann: CCS Appoint Thermo Fisher as Exclusive European Distributor
	LBT LBT Ann: Appendix 3Y - all Directors
	LBT LBT Ann: Notice under s708A - Cleansing Notice
	LBT LBT Ann: Notification regarding unquoted securities - LBT
	LBT LBT Ann: Application for quotation of securities - LBT
	LBT LBT Ann: Non-renounceable Rights Issue Results
	LBT LBT Ann: Application for quotation of securities - LBT
	LBT LBT Ann: Entitlement Offer Letters Mailed to Shareholders
	LBT LBT Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	LBT LBT Ann: Application for quotation of securities - LBT
	LBT LBT Ann: Application for quotation of securities - LBT
	LBT LBT Ann: Proposed issue of securities - LBT
	LBT LBT Ann: Results of Meeting
	LBT LBT Ann: Chair's Address to Shareholders
	LBT LBT Ann: CEO Presentation
	LBT LBT Ann: LBT Receives $1,206,058 R&D Tax Incentive
	LBT LBT Ann: Proposed issue of securities - LBT
	LBT LBT Ann: Rights Issue Prospectus
	LBT LBT Ann: Non-Renounceable Rights Issue
	LBT LBT Ann: $1.5M Funding Awarded for New APAS Instrument
	LBT LBT Ann: Notification of cessation of securities - LBT
	LBT LBT Ann: Notice of Annual General Meeting/Proxy Form
	LBT LBT Ann: BioPhorum Presentation
	LBT LBT Ann: APAS Independence Market Update

Similar Companies

Atomo Diagnostics

AT1

Cochlear

COH

CleanSpace Holdings

CSX

Cyclopharm

CYC

EMvision Medical Devices

EMV

Imagion Biosystems

IBX

ImpediMed

IPD

Micro-X

MX1

Respiri

RSH

SomnoMed

SOM

End of Day Prices

Date	Close	Volume	Change
24-Jan	$0.02	893,948	0.00 (5.56%)
23-Jan	$0.02	224,523	0.00 (0.00%)
21-Jan	$0.02	58,463	0.00 (0.00%)
20-Jan	$0.02	30,000	+0.00 (5.88%)
17-Jan	$0.02	1,008,269	0.00 (5.56%)
14-Jan	$0.02	2,762,573	0.00 (5.26%)
13-Jan	$0.02	28,282	0.00 (0.00%)
10-Jan	$0.02	13,488	0.00 (0.00%)
09-Jan	$0.02	536,866	0.00 (5.00%)
08-Jan	$0.02	1,218,817	0.00 (0.00%)
07-Jan	$0.02	633,888	+0.00 (17.65%)
19-Dec	$0.02	40,000	0.00 (0.00%)
18-Dec	$0.02	1,046,928	0.00 (5.56%)
17-Dec	$0.02	557,500	+0.00 (5.88%)
16-Dec	$0.02	304,833	0.00 (0.00%)
3 up, 5 down, and 7 flat days

High $0.03	Low $0.03	Trades 25	Turnover $28,362	Volume 960,646
30 June 2023 at 4:10pm

High $0.03	Low $0.03	Trades 25	Turnover $28,362	Volume 960,646
30 June 2023 at 4:10pm

LBT Innovations Health Care

$0.030 (0%)

$0.030 (0%)

Followers

Prices

Announcements

Similar Companies

End of Day Prices